Dr. Peter Anthony Quiros, MD

Dr. Quiros practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Quiros' NPI, 1679633507, was assigned on December 11, 2006. Dr. Quiros graduated from Yale School of Medicine in 1996. Dr. Quiros' California license number on file is A64488.

Dr. Quiros' primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Quiros' primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Quiros is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Quiros to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quiros practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Quiros' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Quiros is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Quiros has a license on file in California.

Dmand AI lists dry eye, scleritis and vision problems among the conditions Dr. Quiros treats.

CMS data shows 5,777 Medicare services from Dr. Quiros across 10 procedure codes in 2024, for 155 Medicare patients. Medicare paid $67,730 for them. Every service was in an office.

CMS counts 155 Medicare patients who saw Dr. Quiros in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Quiros' median patient age at 60, with 63% women.

In 2024, Dr. Quiros wrote 185 Medicare Part D claims for 35 patients. 82% of them were for generic drugs. CMS names the drug for 112 of them, across 4 drugs with 11 or more claims each, at $4,432 in total drug cost. In 2023, CMS named 129 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Quiros for performance year 2024, reported as part of a group. Dr. Quiros accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quiros as offering telehealth.

Dmand AI links 8 papers to Dr. Quiros, published from 2011 to 2023. 2017 was the busiest year, with 2. Dr. Quiros' most frequent co-authors are Anthony C. Arnold, MD, Jesse Lee Berry, MD and Laura Bonelli, MD.

Dmand AI links Dr. Quiros to 3 clinical trials, 2 of them phase 2/3 studies. Conditions studied include Optic Neuropathy, Ischemic, Optic Nerve Diseases and Papilledema.

CMS Open Payments shows 11 general payments to Dr. Quiros from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 89% of the total. Genentech, Inc. paid the most, $113.

Dmand AI lists 2 awards for Dr. Quiros.

Dr. Quiros graduated from Yale School of Medicine in 1996. Dr. Quiros is a member of AAO.

Dr. Quiros is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.